IP stock · NPCE stock

IP vs NPCE

International Paper (IP) versus Neuropace Inc (NPCE) — a side-by-side from cached financials, not a winner call.

International Paper (IP) is a packaging & containers company listed on US.

Neuropace Inc (NPCE) is a medical devices company listed on US.

IP does not have a complete income-statement cache yet.

Latest reported NPCE revenue for 2024-12-31 was $79.9M. Net income was -$27.1M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. NPCE currently screens at market cap $312.2M.

IP currently screens at market cap $26.62B and trailing P/E 43.1. NPCE currently screens at market cap $312.2M.

Not investment advice. Open the IP and NPCE stock pages for the full models.

Not investment advice.

Popular Stock Comparisons